Industry Goes On Offensive Against Prescription Pseudoephedrine Trend
This article was originally published in The Tan Sheet
Executive Summary
Drug firms hope to dissuade states from moving drugs that contain methamphetamine precursors to prescription status by funding electronic systems to track nonprescription sales of the products
You may also be interested in...
Electronic Tracking Success Could End Rx-Only Pseudoephedrine In Mississippi
Former Mississippi Gov. Haley Barbour says industry should ask state legislators to repeal the 2010 law that made all PSE drugs Rx-only. CHPA “might get some listeners” if it highlights how the tracking system places less of a financial burden on consumers and the health care system, he says.
Electronic Tracking Success Could End Rx-Only Pseudoephedrine In Mississippi
Former Mississippi Gov. Haley Barbour says industry should ask state legislators to repeal the 2010 law that made all PSE drugs Rx-only. CHPA “might get some listeners” if it highlights how the tracking system places less of a financial burden on consumers and the health care system, he says.
Tennessee Emerges As PSE Battleground With Rx, NPLEx Proposals
The conflict between electronic tracking of pseudoephedrine purchases and shifting the drug ingredient to prescription-only status is elevated in Tennessee as lawmakers offer bills for both anti-methamphetamine strategies.